Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic Patients

NCT01473147 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Exenatide
DRUG: Normal saline

Sponsor

Chang Gung Memorial Hospital